Toxic epidermal necrolysis‐like subacute cutaneous lupus erythematosus

Ryan, Emma; Marshman, Gillian; Astill, David

doi:10.1111/j.1440-0960.2011.00842.x

Cited by 13 publications

(8 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lastly in Leckie's study, a 65 years old diagnosed with rheumatoid athritis for almost 9 year, after 2 weeks addition of 200mg/day of HCQ and developing SJS, it reported that she respond with steroids (14). In addition, in previous studies, there are cases shows the association of using steroid to develop SJS in SLE patients (13,15,16,17,18). Our patient had HCQ and prednisolone intake.…”

Section: Discussionsupporting

confidence: 51%

Stevens Johnson Syndrome Like Skin Lesions in a Patient With Systemic Lupus Erythematosus After Hydroxychloroquine Treatment, a Case

Zengin¹,

Önder²,

Sönmez³

et al. 2020

eams

View full text Add to dashboard Cite

Stevens Johnson Syndrome (SJS) is a clinical syndrome with a high morbidity and mortality, characterized by exfoliation of the skin, generally due to medications, and less frequently due to infections. Most frequently sulphonamides, penicillin, and anti-convulsants were among blamed medications. Systemic lupus erythematosus (SLE) is a systemic auto-immune disorder and skin involvement is frequently seen. Hydroxychloroquine (HCQ) is an important agent which is used in the treatment of SLE and which increases survival. Its side effects include skin reactions. We present here a case of SJS like skin lesions in a 38-year-old female patient with SLE after receiving HCQ.

show abstract

Section: Discussionsupporting

confidence: 51%

Stevens Johnson Syndrome Like Skin Lesions in a Patient With Systemic Lupus Erythematosus After Hydroxychloroquine Treatment, a Case

Zengin¹,

Önder²,

Sönmez³

et al. 2020

eams

View full text Add to dashboard Cite

show abstract

“…The differentiation between TEN and TEN-like CLE can be distinguished by a history of drugs used, clinical presentation, serology, histopathology and DIF studies. [2][3][4][5][6][7] Most patients with TEN-like CLE have no history of medications and have a clinical background of SLE. Cutaneous lesions are usually a gradual progression of the blistering eruptions that predominate on the photo distribution with minimal or limited mucosal involvement.…”

Section: Discussionmentioning

confidence: 99%

Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus in a patient with progressive systemic sclerosis

Aiempanakit

Chiratikarnwong

Juthong

et al. 2018

Lupus

View full text Add to dashboard Cite

A 60-year-old female was diagnosed with progressive systemic sclerosis and interstitial lung disease of two months' duration. The patient was treated for Raynaud phenomenon with aspirin, nifedipine, colchicine, and naproxen. Two weeks after treatment, she developed widespread erythematous patches with blistering eruptions on the face, torso, and extremities, and also had erosion on the oral mucosa. Skin biopsy for histopathology and direct immunofluorescent studies were suggestive of lupus erythematosus. To the best of our knowledge, this is the first case of toxic epidermal necrolysis-like acute cutaneous lupus erythematosus in a patient with progressive systemic sclerosis.

show abstract

“…Vesiculobullous annular SCLE is mainly characterized by erosion and crusting, and more rarely by vesicles and bullae occurring at the active advancing edge of annular SCLE lesions or at the center of the plaque 5,16. Like ACLE, TEN-like sheets of epidermal cleavage evolving from typical photodistributed nonscarring annular or papulosquamous SCLE have rarely been reported 16,23,24. The onset of TEN-like SCLE is gradual.…”

Section: Le-specific Vesiculobullous Diseasesmentioning

confidence: 99%

“…The onset of TEN-like SCLE is gradual. Nikolsky's sign can be either positive or negative, and mucosal involvement is usually absent or minimal 24. Most cases of SCLE-associated vesiculobullous disease lack visceral-organ involvement 22…”

Section: Le-specific Vesiculobullous Diseasesmentioning

confidence: 99%

<p>Vesiculobullous diseases in relation to lupus erythematosus</p>

Rutnin

Chanprapaph

2019

CCID

View full text Add to dashboard Cite

Vesiculobullous lesions in lupus erythematosus (LE) are a rare cutaneous manifestation of cutaneous and/or systemic LE with variable presentation. While the minor forms of LE-associated vesiculobullous disease may cause disfigurement and discomfort, the severe forms can present with hyperacute reaction and life-threatening consequences. Specific LE and aspecific cutaneous LE are defined by the presence or absence of interface change on histopathology that can be applied to vesiculobullous diseases in relation to LE. However, the diagnosis of LE-associated vesiculobullous diseases remains difficult, due to the poorly defined nosology and the similarities in clinical and immunohistopathological features among them. Herein, we thoroughly review the topic of vesiculobullous skin disorders that can be encountered in LE patients and organize them into four groups: LE-specific and aspecific vesiculobullous diseases, LE-related autoimmune bullous diseases, and LE in association to non-autoimmune conditions. We sought to provide an updated overview highlighting the pathogenesis, clinical, histological, and immunopathological features, laboratory findings, and treatments and prognosis among vesiculobullous conditions in LE.

show abstract

Toxic epidermal necrolysis‐like subacute cutaneous lupus erythematosus

Cited by 13 publications

References 7 publications

Stevens Johnson Syndrome Like Skin Lesions in a Patient With Systemic Lupus Erythematosus After Hydroxychloroquine Treatment, a Case

Stevens Johnson Syndrome Like Skin Lesions in a Patient With Systemic Lupus Erythematosus After Hydroxychloroquine Treatment, a Case

Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus in a patient with progressive systemic sclerosis

<p>Vesiculobullous diseases in relation to lupus erythematosus</p>

Contact Info

Product

Resources

About